CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Esophageal self-dilation therapy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03738566
NCT03738566N/ACompleted

Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management: Randomized Controlled Trial

Mayo Clinic·interventional·Posted Nov 13, 2018·Updated May 24, 2023

In Brief

A clinical study evaluating Esophageal self-dilation therapy and Endoscopic therapy with esophageal dilation for Esophageal Dilation and Refractory Benign Esophageal Stricture. Completed, enrolled 26 participants across 1 site.

Detailed Summary

This study is being done to see which treatment is more effective in improving the difficulty of swallowing. Researchers are comparing self-dilation to endoscopic dilation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 13, 2018
Enrollment StartNov 21, 2018
Primary CompletionJul 2, 2021
Study CompletionMay 15, 2022
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 7.6 years ago

Interventions

Esophageal self-dilation therapydevice

Patient learns to pass a polyvinyl dilator orally on a routine basis. Teaching will take over 1-3 training sessions by one of two esophageal physicians and a nurse. Patients will be instructed to start Esophageal self dilation therapy twice a day for at least one week.

Endoscopic therapy with esophageal dilationprocedure

A long, flexible tube is inserted down the throat into the esophagus and the narrow area of the esophagus is dilated, or stretched.